GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses

Zigui Chen1, Dandan Zheng2, Ziren Lin3

  • 1Department of Neurosurgery, Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, China.

Frontiers in Immunology
|October 5, 2023
PubMed
Abstract

Insights

This study explores pan-apoptosis-related genes in glioma, identifying GPX8 as a tumor accelerator. The findings offer potential for predicting glioma progression and improving immunotherapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gliomas are the most common brain tumors.
  • Pan-apoptosis, a non-apoptotic cell death pathway, is understudied in gliomas.

Purpose of the Study:

  • To investigate pan-apoptosis-related genes in glioma.
  • To develop a predictive signature for glioma using machine learning.
  • To examine the role of GPX8 in glioma.

Main Methods:

  • Machine learning techniques for signature development.
  • Prognostic, mutation, and immunological analyses.
  • In vitro (CCK-8, Transwell, EdU) and single-cell RNA sequencing for GPX8 functional analysis.

Main Results:

  • A pan-apoptosis-related gene signature was developed.
  • GPX8 was identified as a tumor accelerator in gliomas.
  • GPX8 promotes tumor cell-macrophage contact and microglial migration.

Conclusions:

  • Pan-apoptosis features may aid in predicting glioma progression and guiding immunotherapy.
  • Further research is needed to confirm GPX8's tumorigenic and immunogenic roles in gliomas.

Related Concept Videos